Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981447 · ClinicalTrials.gov registry record · Phase 3
IV Lacosamide: The Safety of Intravenous Lacosamide
A Phase 3 study of Epilepsy, sponsored by Le Bonheur Children's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01981447 is a Phase 3 study of Epilepsy that has completed, run by Le Bonheur Children's Hospital. The registered enrollment target is 40 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01981447, a Phase 3 study of Epilepsy, has completed, sponsored by Le Bonheur Children's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety of IV Lacosamide in children ages 4-35.
Conditions Studied
Interventions
- DRUG IV Lacosamide
Study Locations (1)
Tennessee
- Lebonheur Children's Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01981447
The ClinicalTrials.gov registry entry for NCT01981447 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The listed sponsor is Le Bonheur Children's Hospital, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which IV Lacosamide is the first listed.
NCT01981447 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT01981447 about?
NCT01981447 is a clinical study titled "IV Lacosamide: The Safety of Intravenous Lacosamide". The purpose of this study is to evaluate the safety of IV Lacosamide in children ages 4-35.
What is the current status of trial NCT01981447?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2010-04. Estimated completion is 2012-08.
What conditions does trial NCT01981447 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT01981447?
The interventions under investigation include: IV Lacosamide (DRUG).
Who is sponsoring clinical trial NCT01981447?
This trial is sponsored by Le Bonheur Children's Hospital, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01981447 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
RECRUITING · Phase 3
-
Lemborexant Treatment of Insomnia Linked to Epilepsy
RECRUITING · Phase 3
-
RNS System NAUTILUS Study
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
COMPLETED · Phase 3
-
Clobazam in Patients With Lennox-Gastaut Syndrome
COMPLETED · Phase 3
-
Pediatric Epilepsy Study
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.